Steven D Young

This inventor holds 34 USPTO granted patents and 1 EPO patent, primarily in HIV Integrase Inhibitors. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Other. Active years: 1985-2010.

USPTO Granted Patents = 34

% Patents Active = 85.3

EPO Patents = 1

Average Co-Inventor Count = 3.6

ph-index = 16

Forward Citations = 675(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

2 out of 834,453

Other

patents

Years Active: 1985-2010

Loading Chart...

Areas of Expertise:

HIV Integrase Inhibitors

Calcium Channel Blockers

Farnesyl-Protein Transferase

Quinazolinone Antagonists

Arylheteroaryl Inhibitors

Alpha1A Adrenergic Antagonists

Biaryl Substituted Imidazole

Fibrinogen Receptor Antagonists

Dioxobenzocyclo-Hepta-Pyridine

Spiro Hexahydro Arylquinolizines

Substituted Indeno Pyridines

Crystal Forms

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7745452 - Quinazolinone T-type calcium channel antagonists (2010-06-29),

2. 7452893 - 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists (2008-11-18),

3. 7279487 - Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors (2007-10-09),

4. 6939964 - Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (2005-09-06),

5. 6921759 - Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors (2005-07-26),

6. 6919351 - Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors (2005-07-19),

7. 6841558 - Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors (2005-01-11),

8. 6639071 - Crystal Forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (2003-10-28),

9. 6380249 - HIV integrase inhibitors (2002-04-30),

10. 6306891 - HIV integrase inhibitors (2001-10-23),

11. 6262055 - HIV integrase inhibitors (2001-07-17),

12. 6093737 - Inhibitors of farnesyl-protein transferase (2000-07-25),

13. 6080870 - Biaryl substituted imidazole compounds useful as farnesyl-protein (2000-06-27),

14. 6077853 - Inhibitors of farnesyl-protein transferase (2000-06-20),

15. 5990107 - Fibrinogen receptor antagonist prodrugs (1999-11-23),

Hello! How may I help you today in the sphere of innovations, inventions, inventors, patent attorneys, and patents?

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]